טוען...
Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
BACKGROUND: In patients with hormone receptor-positive breast cancer, differentiating between patients with a low and a high risk of recurrence is an ongoing challenge. In current practice, prognostic clinical parameters are used for risk prediction. DNA methylation markers have been proven to be of...
שמור ב:
| הוצא לאור ב: | Breast Cancer Res |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6993426/ https://ncbi.nlm.nih.gov/pubmed/32005275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-1250-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|